https://orcid.org/0000-0002-4381-6718
Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Paolo Gisondi, Davide Geat, Francesco Bellinato & Giampiero Girolomoni. (2022) Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis. Expert Opinion on Biological Therapy 22:12, pages 1521-1529.
Read now
Read now
Selda Pelin Kartal, Gökçen Çelik, Oğuz Yılmaz, Eda Öksüm Solak, Büşra Demirbağ Gül, Tuba Kevser Üstünbaş, Melis Gönülal, Sevim Baysak, Esma İnan Yüksel, Begüm Ünlü, Münevver Güven, Ali Bozdağ, Gökhan Çınar, Selim Kartal, Murat Borlu, Müge Güler Özden, Burhan Engin, Server Serdaroğlu, Didem Didar Balcı, Bilal Doğan, Demet Çiçek, Ayça Cordan Yazıcı, Sema Aytekin, Neslihan Şendur, Hayriye Sarıcaoglu, Nida Gelincik Kaçar, Asena Cigdem Doğramacı, Levent Dönmez & Erkan Alpsoy. (2022) The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey. Journal of Dermatological Treatment 33:4, pages 2137-2144.
Read now
Read now
Teodora-Larisa Timis, Ioan-Alexandru Florian, Stefan-Cristian Vesa & Remus-Ioan Orasan. (2022) Treatment of psoriasis – unburdened by fear during SARS-CoV2 menace. Journal of Dermatological Treatment 33:2, pages 662-665.
Read now
Read now
Articles from other publishers (11)
Nazila Ghoreishi Amin, Sepehr Khosravi, Najmolsadat Atefi, Farnoosh Seirafianpour, Sahand Farhoodi & Azadeh Goodarzi. (2023) A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting. Immunity, Inflammation and Disease 11:11.
Crossref
Crossref
H. Arlegui, E. Mahé, M.-A. Richard, Y. De Rycke, M. Viguier, M. Beylot-Barry, A. Dupuy, N. Beneton, P. Joly, D. Jullien, H. Bachelez, É. Sbidian, O. Chosidow, C. Paul & F. Tubach. (2023) Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort. Annales de Dermatologie et de Vénéréologie 150:2, pages 101-108.
Crossref
Crossref
Sophia Quirke-McFarlane, John Weinman, Emma S Cook, Zenas Z N Yiu, Nick Dand, Sinead M Langan, Katie Bechman, Teresa Tsakok, Kayleigh J Mason, Helen McAteer, Freya Meynell, Bolaji Coker, Alexandra Vincent, Dominic Urmston, Amber Vesty, Jade Kelly, Camille Lancelot, Lucy Moorhead, Ines A Barbosa, Herve Bachelez, Francesca Capon, Claudia R Contreras, Claudia De La Cruz, Paola Di Meglio, Paolo Gisondi, Denis Jullien, Jo Lambert, Luigi Naldi, Lluís Puig, Phyllis Spuls, Tiago Torres, Richard B Warren, Hoseah Waweru, James B Galloway, Christopher E M Griffiths, Jonathan N Barker, Sam Norton, Catherine H Smith, Satveer K Mahil, Haleema Alfailakawi, Wisam Alwan, Rosa Andres Ejarque, Ines Barbosa, Carmen Bugarin Diz, Katarzyna Grys, Mahira Hamdy El Sayed, Tran Hong Truong, Masanori Okuse, Dagmara Samselska, Isabella Tosi & Ya-Hsin Wang. (2023) Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey. British Journal of Dermatology 188:5, pages 610-617.
Crossref
Crossref
Vartan Pahalyants, William S. Murphy, Nikolai Klebanov, Chenyue Lu, Nicholas Theodosakis, R. Monina Klevens, Hossein Estir, Evelyn Lilly, Maryam Asgari & Yevgeniy R. Semenov. (2022) Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts. Journal of the American Academy of Dermatology 86:1, pages 252-255.
Crossref
Crossref
Elia Rosi, Maria Thais Fastame, Antonella Di Cesare, Gianmarco Silvi, Nicola Pimpinelli & Francesca Prignano. (2021) Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic. Journal of Clinical Medicine 10:24, pages 5841.
Crossref
Crossref
Khalaf Kridin, Yochai Schonmann, Giovanni Damiani, Avi Peretz, Erez Onn, Dana Tzur Bitan & Arnon D. Cohen. (2021)
Tumor necrosis factor inhibitors are associated with a decreased risk of
COVID
‐19‐associated hospitalization in patients with psoriasis—A population‐based cohort study
. Dermatologic Therapy 34:4.
Crossref
Crossref
S.I. Cho, Y.E. Kim & S.J. Jo. (2020) Association of COVID‐19 with skin diseases and relevant biologics: a cross‐sectional study using nationwide claim data in South Korea*. British Journal of Dermatology 184:2, pages 296-303.
Crossref
Crossref
Satyaki Ganguly, Anchala Parthasaradhi, Jayakar Thomas, Sandeep Arora, Parimalam Kumar, Shekhar Pradhan, Abir Saraswat, Vinay Singh & Haritha Komeravalli. (2021) Psoriasis management during the COVID-19 pandemic: Recommendations by SIG psoriasis (IADVL Academy). Indian Dermatology Online Journal 12:1, pages 58.
Crossref
Crossref
N.D. Loft, A.‐S. Halling, L. Iversen, C. Vestergaard, M. Deleuran, M.K. Rasmussen, C. Zachariae, J.P. Thyssen & L. Skov. (2020) Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey. Journal of the European Academy of Dermatology and Venereology 34:12.
Crossref
Crossref
Ömer Faruk Elmas, Abdullah Demirbaş, Ömer Kutlu, Fatih Bağcıer, Mahmut Sami Metin, Kemal Özyurt, Necmettin Akdeniz, Mustafa Atasoy, Ümit Türsen & Torello Lotti. (2020)
Psoriasis and
COVID
‐19: A narrative review with treatment considerations
. Dermatologic Therapy 33:6.
Crossref
Crossref
Maria A. Montesu, Gabriele Biondi, Giovanni Sotgiu, Federica Sucato & Rosanna Satta. (2020) Biologic drugs during COVID‐19 outbreak. International Journal of Dermatology 59:10, pages 1293-1293.
Crossref
Crossref